MDxHealth SA (MDXH) Earnings Call Analysis
NASDAQ · Healthcare · Diagnostics & Research
Earnings Reports
-
MDXH Q1 2026: Resolve Exit Clears Path for 20%+ Core Growth, Refocuses on Prostate Cancer Platform
May 14, 2026
-
MDXH Q4 2025: Liquid-Based Test Volume Soars 128%, Rebalancing Growth Profile
February 27, 2026
-
MDX Health (MDXH) Q3 2025: Liquid-Based Test Volume Surges 65% as ExoDx Integration Reshapes Growth Path
November 13, 2025
-
MDXH Q2 2025: ExoDx Acquisition to Add $20M+ Revenue, Propelling 30% Growth Ambition
August 06, 2025